Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Journal of the American Heart Association
|
January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)
Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Circulation
|
August 30, 2025
Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study
Jonas Oldgren, Ziad Hijazi, Håkan Arheden, et al.
American Heart Journal
|
June 25, 2025
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
Ziad Hijazi, Lars Wallentin, Håkan Arheden, et al.
BMJ Open
|
September 24, 2017
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis
Dimitrios Venetsanos, Sofia Sederholm Lawesson, Joakim Alfredsson, et al.
International Journal of Cardiology
|
June 30, 2009
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry
Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, et al.
American Heart Journal
|
December 8, 2022
Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry
Mikolaj Skibniewski, Dimitrios Venetsanos, Anders Ahlsson, et al.
American Heart Journal
|
September 29, 2009
Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry
Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, et al.
American Heart Journal
|
November 27, 2008
European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry
Dariusz Dudek, Zbigniew Siudak, Magnus Janzon, et al.
JACC. Cardiovascular Interventions
|
April 7, 2021
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
Dimitrios Venetsanos, Mikolaj Skibniewski, Magnus Janzon, et al.
Journal of the American College of Cardiology
|
February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study
Patricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Journal of the American Heart Association
|
January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)
Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Circulation
|
August 30, 2025
Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study
Jonas Oldgren, Ziad Hijazi, Håkan Arheden, et al.
American Heart Journal
|
June 25, 2025
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
Ziad Hijazi, Lars Wallentin, Håkan Arheden, et al.
BMJ Open
|
September 24, 2017
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis
Dimitrios Venetsanos, Sofia Sederholm Lawesson, Joakim Alfredsson, et al.
International Journal of Cardiology
|
June 30, 2009
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry
Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, et al.
American Heart Journal
|
December 8, 2022
Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry
Mikolaj Skibniewski, Dimitrios Venetsanos, Anders Ahlsson, et al.
American Heart Journal
|
September 29, 2009
Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry
Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, et al.
American Heart Journal
|
November 27, 2008
European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry
Dariusz Dudek, Zbigniew Siudak, Magnus Janzon, et al.
JACC. Cardiovascular Interventions
|
April 7, 2021
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
Dimitrios Venetsanos, Mikolaj Skibniewski, Magnus Janzon, et al.
Journal of the American College of Cardiology
|
February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study
Patricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Page
of 8